Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
doi: 10.1111/1753-0407.12891 Summary Keywords diabetic kidney disease, diabetic nephropathy, GLP-1 receptor agonists, liraglutide, semaglutide, dulaglutide Citation Kawanami D and Takashi Y (2020) GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
investigated SGLT2 expression in human hearts of diabetic and non-diabetic patients, evidencing that the expression of SGLT2 in the explanted heart of diabetics was increased when compared to non-diabetic patients, whereas the presence of SGLT2 in cardiomyocytes accounts for the effects of SGLT2is on metabolic pathways within cardiomyocytes [98]
Tissue Barriers 12:2292461
What works for someone else might not work for you
US$ 28.31
US$ 20.25
US$ 29.22
![Semaglutide vs. Ozempic: RR Wellness Clinic's Guide [2025]](https://cdn.prod.website-files.com/661fb6c93f12c1a427db2537/689f0d069bdc699f796bc7bb_ANYlcfCWX2_k5kikuHM0vsShOjTCzjQcz8rI4c2wVsitdWjIv3nck8W-2_SW5l0QEuIammFNYhKmwM0IM_4Dqm25rhLqHsIFvqRob0uQZihYx3YpiYCaIBtUDV6-i6_let6zQXujHR_RARiwUKB__XE.png)
US$ 22.89
US$ 25.02
US$ 21.50
